Intrauterine Exposure to Acetaminophen and Adverse Developmental Outcomes: Epidemiological Findings and Methodological Issues.
Zeyan LiewAndreas ErnstPublished in: Current environmental health reports (2021)
An increasing number of cohort studies have suggested that maternal use of acetaminophen during pregnancy was associated with increased risk for asthma; neurodevelopmental disorders, especially ADHD and behavioral problems; and genital malformations in the offspring. Oxidative stress and inflammation or endocrine effects are plausible shared biological mechanisms for the exposure to influence multiple developmental outcomes. We discussed methodological challenges that can threaten the validity of these observational data, including confounding and measurement errors. Novel statistical methods and research designs that can be used to mitigate these issues were introduced. Given the high prevalence of use, findings regarding intrauterine exposure to acetaminophen on multiple child health outcomes raise concerns. Research on causal and non-causal mechanisms that might explain these associations should be a priority.
Keyphrases
- oxidative stress
- liver injury
- mental health
- chronic obstructive pulmonary disease
- drug induced
- attention deficit hyperactivity disorder
- autism spectrum disorder
- lung function
- working memory
- patient safety
- adverse drug
- ischemia reperfusion injury
- electronic health record
- high fat diet
- dna damage
- induced apoptosis
- metabolic syndrome
- type diabetes
- birth weight
- adipose tissue
- skeletal muscle
- glycemic control
- cystic fibrosis
- congenital heart disease
- heat shock
- weight gain